EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

Recurrence and metastasis remain the major cause of cancer mortality. Even for early-stage lung cancer, adjuvant chemotherapy yields merely slight increase to patient survival. EF-hand domain-containing protein D2 (EFHD2) has recently been implicated in recurrence of patients with stage I lung adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chi-Chen, Tsai, Sheng-Ta, Lin, Chen-Yuan, Chang, Ling-Chu, Yang, Juan-Cheng, Chen, Guan‐Yu, Sher, Yuh-Pyng, Wang, Shao-Chun, Hsiao, Michael, Chang, Wei‐Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243194/
https://www.ncbi.nlm.nih.gov/pubmed/32446175
http://dx.doi.org/10.1016/j.redox.2020.101571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243194/
https://www.ncbi.nlm.nih.gov/pubmed/32446175
http://dx.doi.org/10.1016/j.redox.2020.101571

Ejemplares similares